These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4984959)

  • 1. [Bacteriocins of Enterobacter liquefaciens. Taxonomic interest of their study].
    Hamon Y; Le Minor L; Peron Y
    C R Acad Hebd Seances Acad Sci D; 1970 Feb; 270(6):886-9. PubMed ID: 4984959
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibilities of Serratia marcescens and Enterobacter liquefaciens.
    Greenup P; Blazevic DJ
    Appl Microbiol; 1971 Sep; 22(3):309-14. PubMed ID: 4330312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on bacteriocin (marcescin) typing of Serratia marcescens. I. Fundamental studies on bacteriocin (marcescin) production and sensitivity (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1977 Sep; 51(9):487-98. PubMed ID: 416153
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study on the epidemiology of Sarratia marcescens using bacteriocin typing].
    Fritsche D; Dostal C; Spieckermann C
    Zentralbl Bakteriol Orig A; 1973 May; 223(4):513-9. PubMed ID: 4146827
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriocins and phages produced by Serratia marcescens.
    Prinsloo HE
    J Gen Microbiol; 1966 Nov; 45(2):205-12. PubMed ID: 5339480
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological typing of Enterobacter aerogenes.
    Gaston MA; Strickland MA; Ayling-Smith BA; Pitt TL
    J Clin Microbiol; 1989 Mar; 27(3):564-5. PubMed ID: 2715326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on group A (phage tail) bacteriocins of Serratia marcescens. I. Phenotypic variation of producer and indicator strains.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):296-304. PubMed ID: 4150063
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on group A (phage tail) bacteriocins of Serratia marcescens. VI. Calcium ion-dependent biological activity of subgroup II bacteriocins.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1976 May; 234(4):528-35. PubMed ID: 779358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nomenclature and taxonomy of bacteria of the tribe Klebsielleae].
    Bondarenko VM; Afanas'eva SM
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Feb; (2):99-105. PubMed ID: 3887817
    [No Abstract]   [Full Text] [Related]  

  • 14. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of group A bacteriocins of Serratia marcescens by nalidixic acid.
    Traub WH; Kleber I; Schaber I
    Nat New Biol; 1973 Oct; 245(144):144-5. PubMed ID: 4582895
    [No Abstract]   [Full Text] [Related]  

  • 16. Medium to aid identification of Serratia marcescens.
    Hamilton RL; Brown WJ
    Am J Med Technol; 1972 Mar; 38(3):73-6. PubMed ID: 4560167
    [No Abstract]   [Full Text] [Related]  

  • 17. Products of defective lysogeny in Serratia marcescens SMG 38 and their activity against Escherichia coli and other Enterobacteria.
    Gratia JP
    J Gen Microbiol; 1989 Jan; 135(1):25-35. PubMed ID: 2674324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Serratia marcescens and Serratia liquefaciens by tests for lipase and phospholipase production.
    Legakis NJ; Nicolas KJ; Xilinas M; Papavassiliou J
    J Med Microbiol; 1978 Aug; 11(3):225-31. PubMed ID: 355631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of induction of group A bacteriocins of Serratia marcescens by rifampin.
    Traub WH
    Experientia; 1972 Aug; 28(8):986-8. PubMed ID: 4561798
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic susceptibility of clinical isolates of Serratia marcescens compared with sensitivity to group A (phage tail) bacteriocins.
    Traub WH
    Chemotherapy; 1978; 24(5):301-13. PubMed ID: 352637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.